Drug Companies Could Face Penalties for Price Gouging Scarce Drugs

Sen. Charles E. Schumer (D-N.Y.) has announced he will propose a bill that would allow the U.S. Department of Justice to punish “unscrupulous drug distributors” who sell drugs in severe shortages at vastly inflated prices, according to an Associated Press report.

Advertisement

The problem has been increasing this year as drug shortages continue. Normally cheap generic injected medicines have become extremely expensive as drug companies mark up prices to reap a profit from desperate hospitals and healthcare facilities.

The Associated Press reported in mid-Sept. 2011 that at least 15 patient deaths have resulted from the shortages. Sen. Schumer’s bill would make price gouging on prescription drugs already in short supply a federal crime.

Sen. Schumer’s bill will be introduced next week, according to the report. Companies that price gouge scarce drugs would receive penalties of up to $500 million per case of price gouging.

Related Articles on Coding, Billing and Collections:

Medicare Funding for Obesity Treatment Sparks Controversy
Minnesota Residents to Try Out Health Care Exchanges Starting Monday
Only 17% of Healthcare Organizations “Fully Prepared” for HIPAA Audit

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in ASC Coding, Billing & Collections

Advertisement

Comments are closed.